A detailed history of Two Sigma Investments, LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 984,361 shares of ARDX stock, worth $5.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
984,361
Previous 2,009,824 51.02%
Holding current value
$5.07 Million
Previous $14.9 Million 54.46%
% of portfolio
0.02%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.28 - $7.57 $5.41 Million - $7.76 Million
-1,025,463 Reduced 51.02%
984,361 $6.78 Million
Q2 2024

Aug 14, 2024

SELL
$5.89 - $9.31 $3.25 Million - $5.14 Million
-552,072 Reduced 21.55%
2,009,824 $14.9 Million
Q1 2024

May 15, 2024

BUY
$6.05 - $9.74 $12.7 Million - $20.4 Million
2,092,603 Added 445.91%
2,561,896 $18.7 Million
Q4 2023

Feb 14, 2024

BUY
$3.29 - $6.64 $149,869 - $302,471
45,553 Added 10.75%
469,293 $2.91 Million
Q3 2023

Nov 14, 2023

SELL
$3.3 - $4.83 $1.64 Million - $2.4 Million
-496,531 Reduced 53.95%
423,740 $1.73 Million
Q2 2023

Aug 14, 2023

SELL
$3.23 - $4.95 $6.22 Million - $9.53 Million
-1,925,114 Reduced 67.66%
920,271 $3.12 Million
Q1 2023

May 15, 2023

BUY
$2.68 - $4.79 $1.35 Million - $2.41 Million
503,972 Added 21.52%
2,845,385 $13.6 Million
Q4 2022

Feb 14, 2023

BUY
$1.22 - $2.85 $2.86 Million - $6.67 Million
2,341,413 New
2,341,413 $6.67 Million
Q4 2021

Feb 14, 2022

SELL
$0.86 - $1.7 $731,834 - $1.45 Million
-850,970 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$1.27 - $8.17 $979,375 - $6.3 Million
771,162 Added 966.27%
850,970 $1.12 Million
Q2 2021

Aug 16, 2021

SELL
$6.55 - $8.98 $3.89 Million - $5.34 Million
-594,565 Reduced 88.17%
79,808 $605,000
Q1 2021

May 17, 2021

BUY
$6.1 - $7.69 $1.55 Million - $1.95 Million
253,520 Added 60.24%
674,373 $4.46 Million
Q4 2020

Feb 16, 2021

SELL
$5.05 - $7.1 $324,169 - $455,763
-64,192 Reduced 13.23%
420,853 $2.72 Million
Q3 2020

Nov 16, 2020

BUY
$5.25 - $7.08 $108,102 - $145,784
20,591 Added 4.43%
485,045 $2.55 Million
Q2 2020

Aug 14, 2020

BUY
$5.37 - $8.11 $1.58 Million - $2.38 Million
293,924 Added 172.36%
464,454 $3.21 Million
Q1 2020

May 15, 2020

SELL
$4.35 - $8.79 $675,494 - $1.36 Million
-155,286 Reduced 47.66%
170,530 $969,000
Q4 2019

Feb 14, 2020

BUY
$4.23 - $8.29 $336,056 - $658,607
79,446 Added 32.25%
325,816 $2.45 Million
Q3 2019

Nov 14, 2019

BUY
$2.15 - $6.28 $64,418 - $188,161
29,962 Added 13.85%
246,370 $1.16 Million
Q2 2019

Aug 14, 2019

SELL
$2.49 - $3.73 $33,107 - $49,594
-13,296 Reduced 5.79%
216,408 $582,000
Q1 2019

May 15, 2019

SELL
$1.88 - $3.35 $385,556 - $687,028
-205,083 Reduced 47.17%
229,704 $643,000
Q4 2018

Feb 14, 2019

SELL
$1.66 - $4.16 $120,511 - $302,003
-72,597 Reduced 14.31%
434,787 $778,000
Q3 2018

Nov 14, 2018

SELL
$3.75 - $4.65 $364,908 - $452,486
-97,309 Reduced 16.09%
507,384 $2.21 Million
Q2 2018

Aug 14, 2018

BUY
$3.7 - $5.8 $2.17 Million - $3.4 Million
586,493 Added 3222.49%
604,693 $2.24 Million
Q1 2018

May 15, 2018

BUY
$5.05 - $7.9 $91,910 - $143,780
18,200 New
18,200 $92,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $796M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.